Neil B. Minkoff, MD, Eugene Wright Jr., MD Where data demonstrated by the FIDELIO-DKD study of finerenone for patients with chronic kidney disease may apply in routine clinical practice. Neil B. Minkoff, MD: Let me turn my question to Dr Wright. There’s this new breakthrough, right? There’s this new drug. It’s been described here by our …
As part of National Marrow Awareness Month (November 2021), we congratulate Dr. Pablo E Pergola of the University of Texas Health Science Center San Antonio — Recognized as an Expertscape Expert in Iron-Deficiency Anemia. Twitter Expertscape
PDF Link – First patient reported outcome data on tenapanor from OPTIMIZE trial demonstrates improved overall patient experience and benefit of one pill twice daily dosing regimen with tenapanor compared to binder therapies – Post-hoc analysis shows comparable phosphate lowering in patients undergoing hemodialysis (HD) and peritoneal dialysis (PD) with a mean change from baseline …
HOURS
Mon-Fri: 9am – 5:00pm
Sat-Sun: Closed
